Atlas Trials

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

Clinical trial NCT05306873 · TERMINATED

Trial details

NCT number
NCT05306873
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2022-11-30
Primary completion
2024-06-13
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.